Martin Kolb

Professor

McMaster University Faculty of Health Sciences

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Imran Satia

McMaster University

CANADA

View details

Mareike Lehmann

Professor of Translational Inflammation Research

Philipps-Universität Marburg

GERMANY

View details

Anna Podolanczuk

Assistant Professor of Medicine

Weill Cornell Medical College

UNITED STATES

View details

Margaret Salisbury

Assistant Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Manali Mukherjee

Assistant Professor

McMaster University

CANADA

View details

Kerri Johannson

Associate Professor

University of Calgary

CANADA

View details

Ayodeji Adegunsoye

University of Chicago

UNITED STATES

View details

Grazyna Kwapiszewska

Medical University of Graz

AUSTRIA

View details

Jose Moran-Mirabal

McMaster University

CANADA

View details

Deborah Assayag

Associate Professor

McGill University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Martin Kolb

Research Interests

Explore related searches

Contact this professor

Articles (19)

The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions

Worsening dyspnoea as a predictor of progression of pulmonary fibrosis

Organic Exposures, Radiologic Features, and Patterns in Fibrotic Interstitial Lung Disease

Validation of a Dyspnea Visual Analog Scale in Fibrotic Interstitial Lung Disease

Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials

Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis

Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease

Sex and Racial Differences in Lung Biopsies for Interstitial Lung Diseases in Canada

Examining the incidence of interstitial lung disease subtypes in South America

A novel take on idiopathic pulmonary fibrosis disease progression: localised autoimmunity

Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based study

Another piece in the pirfenidone puzzle

Reply to: Tacrolimus and the Treatment of Pulmonary Fibrosis

The endothelium in lung fibrosis: a core signaling hub in disease pathogenesis?

A roadmap for developing and engineering in vitro pulmonary fibrosis models

Endothelial cells in pulmonary fibrosis: more than a bystander

Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia

Emerging drugs in the treatment of chronic cough

Design considerations and implications of findings on progressive pulmonary fibrosis from the prospective Canadian Registry for Pulmonary Fibrosis

Collaborators (10)

Imran Satia

Mareike Lehmann

Anna Podolanczuk

Margaret Salisbury

Manali Mukherjee

Kerri Johannson

Ayodeji Adegunsoye

Grazyna Kwapiszewska

Jose Moran-Mirabal

Deborah Assayag

Make your next move.